Table 1.
Patient characteristics and outcome
| Patient characteristics | n = 201 |
|---|---|
| Age, mean ± SD, years |
64 ± 14 |
| Male, n (%) |
136 (68%) |
| Comorbidities, n (%) |
|
| Chronic cardiac diseases |
122 (61%) |
| Chronic respiratory diseases |
78 (39%) |
| Chronic endocrine diseases |
59 (29%) |
| Chronic hepatic diseases |
31 (15%) |
| Chronic neurologic diseases |
33 (16%) |
| Chronic renal insufficiency |
14 (7%) |
| Immunosuppression |
9 (4%) |
| Malignancy |
21 (10%) |
| Human immunodeficiency virus infection |
5 (2.5%) |
| Knaus chronic health status score |
|
| Class A |
32 (16%) |
| Class B |
73 (36%) |
| Class C |
64 (32%) |
| Class D |
18 (9%) |
| Nonassessable |
14 (7%) |
| ICU admission diagnoses, n (%) |
|
| Cardiovascular including septic shock |
68 (34%) |
| Surgery |
46 (23%) |
| Pulmonary including pneumonia |
43 (21%) |
| Neurologic |
19 (9%) |
| Infection |
10 (5%) |
| Gastrointestinal |
6 (3%) |
| Endocrine |
4 (2%) |
| Traumatic |
5 (2%) |
| Hematologic or malignancy |
0 (0%) |
| SAPS II ICU admission, mean ± SD |
51 ± 17 |
| SOFA ICU admission, mean ± SD |
9 ± 4 |
| Hospital outcomes |
|
| Duration of MV, mean ± SD, days |
37 ± 20 |
| Duration of MV if died in ICU, mean ± SD, days |
23 ± 29 |
| Weaning from MV, n (%) |
104 (52%) |
| Tracheostomy during ICU stay, n (%) |
61 (30%) |
| ICU length of stay, mean ± SD, days |
41 ± 21 |
| Death in ICU, n (%) |
83 (41%) |
| One-year mortality, n (%) | 120 (60%) |
SD, standard deviation; MV, mechanical ventilation; ICU, intensive care unit; SAPS, simplified acute physiology score; SOFA, sequential organ failure assessment.